Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques

NCT02176109 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT02176109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02176109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rôle Pronostique Des métabolismes du Stress Oxydatif et du Fer Dans Les Leucémies Aiguës Myéloblastiques
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2013
Completion date
June 30, 2018
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, diagnosis, iron, oxydative stress